Ayşe Yılmaz

High Readmission RiskLow Health Literacy
MRN:MRN-2024-081547
Age / Gender:72 yrs / Female
DOB:1952-04-16
Discharged:2026-05-10
Physician:Dr. Elif Kaya
Dept:Cardiology
Diagnosis:Heart failure with reduced ejection fraction
Living:Lives alone
Caregiver:Daughter visits 1-2 times per week

Critical Safety Alerts3

  • 1High risk of diuretic-induced hypokalemia; serum potassium monitoring is critical in 72 hours.
  • 2Increased risk of fall/syncope due to combination of HFrEF medications and increased diuretic dosing.
  • 3Patient needs clear guidance on differentiating fluid overload from dehydration symptoms.

Missing Information

  • Baseline creatinine and potassium levels for comparison.
  • Specific instructions on what to do if weight fluctuates significantly.

Clinician Summary

Primary Diagnosis

HFrEF (LVEF 35%) with acute on chronic volume overload.

Medication Changes

  • Furosemide: Increased from 40mg BID to 80mg BID.
  • Continue lisinopril, metoprolol, atorvastatin, and metformin as previously prescribed.

Important Labs & Findings

  • Potassium 3.8 mmol/L (borderline low).
  • Creatinine 1.2 mg/dL.
  • BNP 450 pg/mL.

Red Flag Risks

  • Worsening dyspnea or orthopnea.
  • Significant weight gain (e.g., >3 lbs in a day or >5 lbs in a week).
  • Symptomatic hypotension or syncope.
  • Severe fatigue or signs of electrolyte disturbance (e.g., muscle weakness, palpitations).

Follow-up Plan

Lab Work
72 hrs

Electrolyte panel in 72 hours to assess for hypokalemia.

Follow-up Visit
7 days

Cardiology follow-up in 7 days.

Monitoring
Daily

Patient instructed on daily morning weight tracking.

Safety Notes

  • Patient is at significant risk for hypokalemia due to dose increase of loop diuretic.
  • High risk of falls due to potential orthostatic hypotension from antihypertensive regimen and diuresis.
  • Requires close monitoring of renal function and electrolytes given underlying CKD stage 3.
  • Transition care requires high vigilance for signs of volume overload or rapid dehydration.

Patient Home Care Plan

Your Health Condition

Heart Failure: This means your heart is having a hard time pumping blood effectively, causing fluid to build up in your body.

Medicine Schedule

Morning
  • Furosemide (Water Pill): 80mg
  • Take other heart and diabetes medications as previously instructed.
Afternoon
  • Continue any other scheduled maintenance medications.
Evening
  • Furosemide (Water Pill): 80mg
  • Take other maintenance medications as previously instructed.
Before Sleep
  • No new medications to add here; keep your routine.

Daily Tasks

  • Weigh yourself every morning before breakfast, after using the bathroom, and wearing similar clothing.
  • Check your legs and feet daily for new or worsening swelling.
  • Take your heart and fluid medications exactly as prescribed.
  • Rise slowly from sitting or lying down to avoid dizziness.

Warning Signs — Call Hospital If:

  • You gain more than 3 pounds in one day or 5 pounds in a week.
  • You feel very dizzy or lightheaded when standing.
  • You have a hard time catching your breath, even while resting.
  • You notice sudden, severe weakness or heart palpitations.
  • You have swelling in your legs that is getting worse.

Appointments & Tests

  • Blood test for electrolytes: In 3 days (72 hours).
  • Cardiology check-up: In 7 days.

Important Reminders

  • Keep a log of your daily weights.
  • Drink only the amount of fluids your doctor recommended.
  • Watch for dizziness when you stand up quickly.
  • Do not skip blood tests for your electrolyte levels.

AI Explainability — Why These Risks Were Flagged

Furosemide dose doubled (40mg → 80mg BID)Hypokalemia & dehydrationHigh
Potassium 3.8 mmol/L (borderline low)Electrolyte imbalanceHigh
Patient lives alone, low health literacyMedication non-adherenceHigh
CKD stage 3 with creatinine 1.2Renal function deteriorationMedium
Orthostatic hypotension riskFalls & syncopeHigh

This discharge plan was generated by analyzing admission records, lab results, medication history, and clinical notes using a structured AI agent.

Disclaimer: This AI-generated plan must be reviewed by a licensed clinician before patient distribution.